Paraneoplastic cerebellar degeneration

Albert, 2000, Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration, Ann Neurol, 47, 9, 10.1002/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I Antoine, 2000, [18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies, Ann Neurol, 48, 105, 10.1002/1531-8249(200007)48:1<105::AID-ANA16>3.0.CO;2-G Bataller, 2004, Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer, Neurology, 62, 778, 10.1212/01.WNL.0000113749.77217.01 Bernal, 2003, Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease, Neurology, 60, 230, 10.1212/01.WNL.0000041495.87539.98 Brain, 1951, Subacute cortical cerebellar degeneration and its relation to carcinoma, J Neurol Neurosurg Psychiatry, 14, 59, 10.1136/jnnp.14.2.59 Brashear, 1989, Anticerebellar antibodies in neurologically normal patients with ovarian neoplasms, Neurology, 39, 1605, 10.1212/WNL.39.12.1605 Brock, 2001, Anti-Yo antibody-positive cerebellar degeneration associated with endometrial carcinoma: case report and review of the literature, Clin Oncol (R Coll Radiol), 13, 476 Candler, 2004, A follow up study of patients with paraneoplastic neurological disease in the United Kingdom, J Neurol Neurosurg Psychiatry, 75, 1411, 10.1136/jnnp.2003.025171 Chan, 2001, ANNA-3 anti-neuronal nuclear antibody marker of lung cancer-related autoimmunity, Ann Neurol, 50, 301, 10.1002/ana.1127 Clouston, 1992, Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome, Neurology, 42, 1944, 10.1212/WNL.42.10.1944 Cocconi, 1985, Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis, A case report. Cancer, 56, 2318 Dalmau, 1999, Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders, Brain, 122, 27, 10.1093/brain/122.1.27 Darnell, 2000, Cdr2, a target antigen of naturally occurring human tumor immunity, is widely expressed in gynecological tumors, Cancer Res, 60, 2136 Darnell, 2000, cdr2-specific CTLs are detected in the blood of all patients with paraneoplastic cerebellar degeneration analyzed, Ann Neurol, 48, 270, 10.1002/1531-8249(200008)48:2<270::AID-ANA25>3.0.CO;2-Y Darnell, 2003, Paraneoplastic syndromes involving the nervous system, N Engl J Med, 349, 1543, 10.1056/NEJMra023009 Eerola, 2000, A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma, Clin Cancer Res, 6, 1875 Fukuda, 2003, Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome, Ann Neurol, 53, 21, 10.1002/ana.10392 Galanis, 1999, Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy, Cancer Immunol Immunother, 48, 85, 10.1007/s002620050551 Giometto, 1997, Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system, Neuropathol Appl Neurobiol, 23, 468, 10.1111/j.1365-2990.1997.tb01323.x Graus, 2001, Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients, Brain, 124, 1138, 10.1093/brain/124.6.1138 Graus, 2002, P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer, Neurology, 59, 764, 10.1212/WNL.59.5.764 Greenfield, 1934, Subacute spino-cerebellar degeneration occurring in elderly patients, Brain, 57, 161, 10.1093/brain/57.2.161 Greenlee, 1983, Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma, Ann Neurol, 14, 609, 10.1002/ana.410140603 Hammack, 1990, Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies, Mayo Clin Proc, 65, 1423, 10.1016/S0025-6196(12)62166-1 Hammack, 1992, Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease, Neurology, 42, 1938, 10.1212/WNL.42.10.1938 Hetzel, 1990, Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume, Mayo Clinic Proc, 65, 1558, 10.1016/S0025-6196(12)62189-2 Keime-Guibert, 2000, Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone, J Neurol Neurosurg Psychiatry, 68, 479, 10.1136/jnnp.68.4.479 Kiers, 1991, Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma, Mayo Clin Proc, 66, 1209, 10.1016/S0025-6196(12)62471-9 Konarski, 2005, Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?, J Psychiatry Neurosci, 30, 178 Land, 2005, Gynaecology meets neurology: paraneoplastic cerebellar degeneration, Aust N Z J Obstet Gynaecol, 45, 79, 10.1111/j.1479-828X.2005.00330.x Levisohn, 2000, Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population, Brain, 123, 1041, 10.1093/brain/123.5.1041 Lucchinetti, 1998, Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies, Neurology, 50, 652, 10.1212/WNL.50.3.652 Mowzoon, 2000, Successful immunosuppressant therapy of severe progressive cerebellar degeneration and sensory neuropathy: a case report, J Neurol Sci, 178, 63, 10.1016/S0022-510X(00)00353-1 Oguro-Okano, 1992, Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma, Mayo Clin Proc, 67, 1150, 10.1016/S0025-6196(12)61144-6 Paslawski, 2005, Speech and language findings associated with paraneoplastic cerebellar degeneration, Am J Speech Lang Pathol, 14, 200, 10.1044/1058-0360(2005/020) Peterson, 1992, Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients, Neurology, 42, 1931, 10.1212/WNL.42.10.1931 Pittock, 2003, Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments, Ann Neurol, 53, 580, 10.1002/ana.10518 Pittock, 2004, Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome, Ann Neurol, 56, 715, 10.1002/ana.20269 Rewcastle, 1963, Subacute cerebellar degeneration with Hodgkin's disease, Arch Neurol, 9, 407, 10.1001/archneur.1963.00460100095011 Rojas, 2000, Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies, Neurology, 55, 713, 10.1212/WNL.55.5.713 Rojas-Marcos, 2003, Spectrum of paraneoplastic neurological disorders in women with breast and gynecologic cancer, Medicine (Baltimore), 82, 216, 10.1097/01.md.0000076004.64510.ce Shams'ili, 2003, Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients, Brain, 126, 1409, 10.1093/brain/awg133 Sillevis Smitt, 2000, Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor, N Engl J Med, 342, 21, 10.1056/NEJM200001063420104 Stark, 1995, Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration, Arch Neurol, 52, 814, 10.1001/archneur.1995.00540320098016 Trotter, 1976, Cerebellar degeneration with Hodgkin disease: an immunological study, Arch Neurol, 33, 660, 10.1001/archneur.1976.00500090066014 Vernino, 2000, New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity, Ann Neurol, 47, 297, 10.1002/1531-8249(200003)47:3<297::AID-ANA4>3.0.CO;2-4 Vernino, 2004, Immunomodulatory treatment trial for paraneoplastic neurological disorders, Neuro-oncol, 6, 55, 10.1215/S1152851703000395 Voltz, 1999, A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer, N Engl J Med, 340, 1788, 10.1056/NEJM199906103402303 Yu, 2001, CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity, Ann Neurol, 49, 146, 10.1002/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E Zhang, 2003, Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer, N Engl J Med, 348, 203, 10.1056/NEJMoa020177